Ledipasvir/sofosbuvir +/- RBV Retreatment in HCV Patients Ledipasvir/sofosbuvir +/- RBV Retreatment in HCV Patients

Is ledipasvir/sofosbuvir with or without ribavirin a viable option for treating patients with HCV genotype 1 for whom treatment with simeprevir/sofosbuvir had previously failed?Alimentary Pharmacology & Therapeutics
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news